NCT02043184View on ClinicalTrials.gov

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

NACompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Prostatic NeoplasmsBreast NeoplasmsColorectal NeoplasmsMelanomaLeukemia
Interventions
BEHAVIORAL

Interactive Voice Response (IVR) Reminders

Reminders tailored to the oral cancer medication(s) the patients are receiving delivered by interactive voice response system with referral to a self-management guide when symptoms exceed thresholds.

Trial Locations (8)

15232

University of Pittsburgh, Pittsburgh

43210

Ohio State University, Columbus

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

48910

MSU Breslin Cancer Center, Lansing

48912

Sparrow Cancer Center, Lansing

60611

Northwestern University, Chicago

06520

Yale University, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Michigan State University

OTHER

NCT02043184 - Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR | Biotech Hunter | Biotech Hunter